Pulsed Radiofrequency Versus 5% Dextrose Injection in Chronic Plantar Fasciitis
RecruitingNot applicableNCT07688876
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This prospective, two-center, randomized controlled clinical trial aims to compare the effectiveness of ultrasound-guided pulsed radiofrequency and 5% dextrose injection in patients with chronic plantar fasciitis. Eligible participants will be randomized into two parallel groups. One group will receive ultrasound-guided pulsed radiofrequency treatment, and the other group will receive ultrasound-guided 5% dextrose injection using the peppering technique. All participants will receive a home-based plantar fascia stretching exercise program. Outcomes will be assessed at baseline, 3 weeks, 6 weeks, and 12 weeks after treatment. The primary outcome will be pain intensity measured by the Numeric Rating Scale. Secondary outcomes will include foot function, activity-related pain, ankle-hindfoot function, and health-related quality of life.
Study details
- Official title
- Comparison of Ultrasound-Guided Pulsed Radiofrequency and 5% Dextrose Injection in Patients With Chronic Plantar Fasciitis: A Randomized Controlled Trial
- Conditions
- Chronic Plantar Fasciitis
- Chronic Heel Pain
- Foot Pain
- Interventions
- Procedure: Ultrasound-Guided Pulsed Radiofrequency Treatment
- Procedure: Ultrasound-Guided 5% Dextrose Injection
- Sponsor
- Ankara City Hospital Bilkent
- Start date
- 2026-01-01
- Primary completion
- 2027-01-01
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of chronic plantar fasciitis based on medical history and physical examination * Heel pain resistant to conservative treatment for at least 12 weeks * Age between 18 and 70 years * Willingness to participate in the study and provide written informed consent Exclusion Criteria: * Congenital or acquired disease that may impair or prevent foot function, such as rheumatoid arthritis, hemiplegia, congenital foot deformity, traumatic foot or leg amputation, or fracture sequelae * Local infection or skin disease at the treatment site * Bleeding disorder or use of anticoagulant medication within the last week * Disease causing mental dysfunction, such as uncontrolled Parkinson disease or Alzheimer disease * Previous surgery for plantar fasciitis * Refusal to participate in the study or inability to provide informed consent * Failure to attend follow-up visits after treatment * Request to withdraw from the study * Pregnancy or suspected pregnancy * Presence of a cardiac pacemaker * History of epilepsy * Active or previous malignancy * Rheumatologic disease
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07688876